Blood Transfus. 2007 Nov;5(4):204-9. doi: 10.2450/2007.0023-07.

Blood product support for delivery in severe factor X deficiency: the use of thrombin generation to guide therapy.

Blood transfusion = Trasfusione del sangue

Joost J van Veen, Kingsley K Hampton, Rhona Maclean, Fiona Fairlie, Michael Makris

PMID: 19204776 PMCID: PMC2581915 DOI: 10.2450/2007.0023-07

Abstract

BACKGROUND: Severe FX deficiency is a rare disorder with a variable bleeding tendency but spontaneous life threatening haemorrhage can occur. Treatment for invasive procedures and spontaneous bleeding is with prothrombin complex concentrates (PCC). When used in large or repetitive doses these are associated with a thrombotic tendency. FX:C levels of 0.15 - 0.30 IU/ mL are thought to be haemostatic during surgery . There is only limited information on the outcome and management of pregnancy in severe FX deficiency. Caesarean section is suggested as delivery mode to reduce the risk of intracranial/abdominal neonatal haemorrhage, but successful vaginal deliveries are also described. The calibrated automated thrombin generation assay (CAT) is a global coagulation test that measures the time course of thrombin generation. It has been reported to correlate with prothrombotic states and the severity of bleeding in rare coagulation disorders. The variability in phenotype, the uncertainty of the minimal haemostatic FX:C concentration and the association of PCC's with thrombosis make thrombin generation of interest in the management of FX deficient patients.

PATIENT: We describe the use of CAT as a possible means to monitor treatment with PCC (Beriplex) in a patient with severe FX deficiency (FX:C < 0.01 IU/mL) during successful vaginal delivery and epidural anaesthesia.

RESULTS: Thrombin generation was normal at FX:C 0.80 IU/mL but only borderline normal at FX:C 0.25 IU/mL. Repetitive doses over 3 days increased thrombin generation to the upper limit of normal at FX:C 0.25 IU/mL consistent with a prothrombotic tendency after multiple doses. The increase in thrombin generation was not related to prothrombin levels.

CONCLUSION: The data suggest that CAT may be used to monitor treatment with PCC in FX deficiency. Higher levels than previously thought may be needed to normalize thrombin generation. Further studies into the correlation with bleeding or thrombosis are needed before the approach can be accepted in clinical practice.

Keywords: FX deficiency; endogenous thrombin potential; pregnancy; prothrombin complex concentrate; thrombin generation

References

1. Thromb Haemost. 2005 Dec;94(6):1338-9 - PubMed
2. Ann Fr Anesth Reanim. 2002 Jun;21(6):521-4 - PubMed
3. Blood Coagul Fibrinolysis. 2002 Oct;13(7):653-5 - PubMed
4. Thromb Haemost. 2002 Oct;88(4):576-82 - PubMed
5. Thromb Res. 1999 Aug 15;95(4 Suppl 1):S13-7 - PubMed
6. Haemophilia. 2004 Sep;10(5):593-628 - PubMed
7. Pathophysiol Haemost Thromb. 2003;33(1):4-15 - PubMed
8. JAMA. 2006 Jul 26;296(4):397-402 - PubMed
9. Haemophilia. 2005 Jul;11(4):326-34 - PubMed
10. Haemophilia. 2004 Sep;10(5):665-8 - PubMed
11. J Thromb Haemost. 2004 Nov;2(11):1954-9 - PubMed
12. Blood Coagul Fibrinolysis. 2004 Jul;15(5):405-11 - PubMed
13. Am J Hematol. 1994 Jul;46(3):241-4 - PubMed
14. Blood Coagul Fibrinolysis. 2008 Apr;19(3):183-9 - PubMed
15. J Neurosurg Spine. 2004 Sep;1(2):232-6 - PubMed
16. Blood. 2004 Sep 1;104(5):1243-52 - PubMed
17. Haemophilia. 2003 Jan;9(1):1-23 - PubMed
18. Thromb Haemost. 2005 Mar;93(3):475-80 - PubMed
19. Swiss Med Wkly. 2001 Oct 6;131(39-40):582-7 - PubMed
20. Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3106-11 - PubMed
21. Obstet Gynecol. 1996 Oct;88(4 Pt 2):723 - PubMed
22. Blood. 1999 Oct 1;94(7):2169-78 - PubMed
23. Pathophysiol Haemost Thromb. 2002 Sep-Dec;32(5-6):249-53 - PubMed

Publication Types

• Journal Article